nach oben

Journal of Inherited Metabolic Disease

Erschienen in:

01.09.2013 | Original Article

Prediction of the functional effect of novel SLC25A13 variants using a S. cerevisiae model of AGC2 deficiency

verfasst von: Parith Wongkittichote, Sumalee Tungpradabkul, Duangrurdee Wattanasirichaigoon, Laran T. Jensen

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

AGC2, a member of the mitochondrial carrier protein family, is as an aspartate-glutamate carrier and is important for urea synthesis and the maintenance of the malate-aspartate shuttle. Mutations in SLC25A13, the gene encoding AGC2, result in two age dependent disorders: neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and type II citrullinemia (CTLN2). The clinical features of CTLN2 are very similar to those of other urea cycle disorders making a clear diagnosis difficult. Analysis of the SLC25A13 gene sequence can provide a definitive diagnosis, however the predictive value of DNA sequencing requires that the disease association of variants be characterized. We utilized the yeast Saccharomyces cerevisiae lacking AGC1 as a model system to study the effect on the function of AGC2 variants and confirmed that this system is capable of distinguishing between AGC2 variants with normal (p.Pro632Leu) or impaired function (p.Gly437Glu, p.Gly531Asp, p.Thr546Met, p.Leu598Arg and p.Glu601Lys). Three novel AGC2 genetic variants, p.Met1? (c.2T>C), p.Pro502Leu (c.1505C>T), and p.Arg605Gln (c.1814G>A) were investigated and our analysis revealed that p.Pro502Leu and p.Arg605Gln substitutions in the AGC2 protein were without effect and these variants were fully functional. The p.Met1? mutant is capable of expressing a truncated p.Met1_Phe34del AGC2 variant, however this protein is not functional due to disruptions in a calcium binding EF hand as well as incorrect intracellular localization. Our study demonstrates that the characterization of AGC2 expressed in yeast cells is a powerful technique to investigate AGC2 variants, and this analysis should aid in establishing the disease association of novel variants.

Nur mit Berechtigung zugänglich

Akke M, Drakenberg T, Chazin WJ (1992) Three-dimensional solution structure of Ca(2+)-loaded porcine calbindin D9k determined by nuclear magnetic resonance spectroscopy. Biochemistry 31(4):1011–1020CrossRefPubMed

Aronov S, Gelin-Licht R, Zipor G, Haim L, Safran E, Gerst JE (2007) mRNAs encoding polarity and exocytosis factors are cotransported with the cortical endoplasmic reticulum to the incipient bud in Saccharomyces cerevisiae. Mol Cell Biol 27(9):3441–3455CrossRefPubMedPubMedCentral

Balcavage WX, Mattoon JR (1968) Properties of Saccharomyces cerevisiae mitochondria prepared by a mechanical method. Biochim Biophys Acta 153(3):521–530CrossRefPubMed

Begum L, Jalil MA, Kobayashi K et al (2002) Expression of three mitochondrial solute carriers, citrin, aralar1 and ornithine transporter, in relation to urea cycle in mice. Biochim Biophys Acta 1574(3):283–292CrossRefPubMed

Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T (2009) Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 4(1):1–13CrossRefPubMed

Brachmann CB, Davies A, Cost GJ et al (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14:115–132CrossRefPubMed

Cavero S, Vozza A, del Arco A et al (2003) Identification and metabolic role of the mitochondrial aspartate-glutamate transporter in Saccharomyces cerevisiae. Mol Microbiol 50(4):1257–1269CrossRefPubMed

Contreras L, Gomez-Puertas P, Iijima M, Kobayashi K, Saheki T, Satrustegui J (2007) Ca2+ activation kinetics of the two aspartate-glutamate mitochondrial carriers, aralar and citrin: role in the heart malate-aspartate NADH shuttle. J Biol Chem 282(10):7098–7106CrossRefPubMed

Cullin C, Minvielle-Sebastia L (1994) Multipurpose vectors designed for the fast generation of N- or C-terminal epitope-tagged proteins. Yeast 10(1):105–112CrossRefPubMed

del Arco A, Agudo M, Satrustegui J (2000) Characterization of a second member of the subfamily of calcium-binding mitochondrial carriers expressed in human non-excitable tissues. Biochem J 345(Pt 3):725–732CrossRefPubMedPubMedCentral

den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15(1):7–12CrossRef

Dimmock D, Maranda B, Dionisi-Vici C et al (2009) Citrin deficiency, a perplexing global disorder. Mol Genet Metab 96(1):44–49CrossRefPubMed

Fiermonte G, Parisi G, Martinelli D et al (2011) A new Caucasian case of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD): a clinical, molecular, and functional study. Mol Genet Metab 104(4):501–506CrossRefPubMed

Fu HY, Zhang SR, Wang XH, Saheki T, Kobayashi K, Wang JS (2011) The mutation spectrum of the SLC25A13 gene in Chinese infants with intrahepatic cholestasis and aminoacidemia. J Gastroenterol 46(4):510–518CrossRefPubMed

Gietz RD, Schiestl RH (1991) Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier. Yeast 7(3):253–263CrossRefPubMed

Hachisu M, Oda Y, Goto M et al (2005) Citrin deficiency presenting with ketotic hypoglycaemia and hepatomegaly in childhood. Eur J Pediatr 164(2):109–110CrossRefPubMed

Hartwell LH (2004) Yeast and cancer. Biosci Rep 24(4–5):523–544CrossRefPubMed

Hobbs AE, Srinivasan M, McCaffery JM, Jensen RE (2001) Mmm1p, a mitochondrial outer membrane protein, is connected to mitochondrial DNA (mtDNA) nucleoids and required for mtDNA stability. J Cell Biol 152(2):401–410CrossRefPubMedPubMedCentral

Hughes AL, Powell DW, Bard M et al (2007) Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 5(2):143–149CrossRefPubMed

Iijima M, Jalil A, Begum L et al (2001) Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin. Adv Enzyme Regul 41:325–342CrossRefPubMed

Ikeda S, Kawa S, Takei Y et al (2004) Chronic pancreatitis associated with adult-onset type II citrullinemia: clinical and pathologic findings. Ann Intern Med 141(7):W109–W110CrossRefPubMed

Jensen LT, Carroll MC, Hall MD, Harvey CJ, Beese SE, Culotta VC (2009) Down-regulation of a manganese transporter in the face of metal toxicity. Mol Biol Cell 20(12):2810–2819CrossRefPubMedPubMedCentral

Kobayashi K, Saheki T (1993) Citrin deficiency

Kobayashi K, Sinasac DS, Iijima M et al (1999) The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 22(2):159–163CrossRefPubMed

Kobayashi K, Ushikai M, Song Y-Z et al (2008) Overview of citrin deficiency: SLC25A13 mutations and the frequency. J Appl Clin Pediatr 23(20):1553–1557

Komatsu M, Yazaki M, Tanaka N et al (2008) Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J Hepatol 49(5):810–820CrossRefPubMed

Kunji ER (2004) The role and structure of mitochondrial carriers. FEBS Lett 564(3):239–244CrossRefPubMed

Lasorsa FM, Pinton P, Palmieri L, Fiermonte G, Rizzuto R, Palmieri F (2003) Recombinant expression of the Ca(2+)-sensitive aspartate/glutamate carrier increases mitochondrial ATP production in agonist-stimulated Chinese hamster ovary cells. J Biol Chem 278(40):38686–38692CrossRefPubMed

Lu YB, Kobayashi K, Ushikai M et al (2005) Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J Hum Genet 50(7):338–346CrossRefPubMed

Mutoh K, Kurokawa K, Kobayashi K, Saheki T (2008) Treatment of a citrin-deficient patient at the early stage of adult-onset type II citrullinaemia with arginine and sodium pyruvate. J Inherit Metab Dis 31(Suppl 2):S343–S347CrossRefPubMed

Nagasaka H, Okano Y, Tsukahara H et al (2009) Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin-deficiency even during the silent period. Mol Genet Metab 97(1):21–26CrossRefPubMed

Palmieri F (2004) The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch 447(5):689–709CrossRefPubMed

Palmieri F (2008) Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 1777(7–8):564–578CrossRefPubMed

Palmieri L, Pardo B, Lasorsa FM et al (2001) Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20(18):5060–5069CrossRefPubMedPubMedCentral

Palmieri F, Agrimi G, Blanco E et al (2006) Identification of mitochondrial carriers in Saccharomyces cerevisiae by transport assay of reconstituted recombinant proteins. Biochim Biophys Acta 1757(9–10):1249–1262CrossRefPubMed

Pebay-Peyroula E, Dahout-Gonzalez C, Kahn R, Trezeguet V, Lauquin GJ, Brandolin G (2003) Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 426(6962):39–44CrossRefPubMed

Perocchi F, Mancera E, Steinmetz LM (2008) Systematic screens for human disease genes, from yeast to human and back. Mol Biosyst 4(1):18–29CrossRefPubMed

Pfanner N, Hoeben P, Tropschug M, Neupert W (1987) The carboxyl-terminal two-thirds of the ADP/ATP carrier polypeptide contains sufficient information to direct translocation into mitochondria. J Biol Chem 262(31):14851–14854PubMed

Ralser M, Heeren G, Breitenbach M, Lehrach H, Krobitsch S (2006) Triose phosphate isomerase deficiency is caused by altered dimerization–not catalytic inactivity–of the mutant enzymes. PLoS One 1:e30CrossRefPubMedPubMedCentral

Ramos M, del Arco A, Pardo B et al (2003) Developmental changes in the Ca2+-regulated mitochondrial aspartate-glutamate carrier aralar1 in brain and prominent expression in the spinal cord. Brain Res Dev Brain Res 143(1):33–46CrossRefPubMed

Saheki T, Kobayashi K (2002) Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 47(7):333–341CrossRefPubMed

Saheki T, Kobayashi K, Iijima M et al (2005) Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Hepatol Res 33(2):181–184CrossRefPubMed

Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31(13):3381–3385CrossRefPubMedPubMedCentral

Sherman F, Fink GR, Lawrence CW (1978) Methods in yeast genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor

Sikorski RS, Hieter P (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces ceresiviae. Genetics 122:19–27PubMedPubMedCentral

Sirrenberg C, Endres M, Folsch H, Stuart RA, Neupert W, Brunner M (1998) Carrier protein import into mitochondria mediated by the intermembrane proteins Tim10/Mrs11 and Tim12/Mrs5. Nature 391(6670):912–915CrossRefPubMed

Soeda J, Yazaki M, Nakata T et al (2008) Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report. J Clin Gastroenterol 42(7):855–860CrossRefPubMed

Song YZ, Ushikai M, Sheng JS, Iijima M, Kobayashi K (2007) SLC25A13 gene mutation analysis in a pedigree of neonatal intrahepatic cholestasis caused by citrin deficiency. Zhonghua Er Ke Za Zhi 45(6):408–412PubMed

Steinmetz LM, Scharfe C, Deutschbauer AM et al (2002) Systematic screen for human disease genes in yeast. Nat Genet 31(4):400–404PubMed

Sundin BA, Chiu CH, Riffle M, Davis TN, Muller EG (2004) Localization of proteins that are coordinately expressed with Cln2 during the cell cycle. Yeast 21(9):793–800CrossRefPubMed

Tabata A, Sheng JS, Ushikai M et al (2008) Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency. J Hum Genet 53(6):534–545CrossRefPubMed

Vriend G (1990) Parameter relation rows: a query system for protein structure function relationships. Protein Eng 4(2):221–223CrossRefPubMed

Yamaguchi N, Kobayashi K, Yasuda T et al (2002) Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Hum Mutat 19(2):122–130CrossRefPubMed

Yazaki M, Takei Y, Kobayashi K, Saheki T, Ikeda S (2005) Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2). Intern Med 44(3):188–195CrossRefPubMed

Titel: Prediction of the functional effect of novel SLC25A13 variants using a S. cerevisiae model of AGC2 deficiency
verfasst von: Parith Wongkittichote
Sumalee Tungpradabkul
Duangrurdee Wattanasirichaigoon
Laran T. Jensen
Publikationsdatum: 01.09.2013
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 5/2013
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-012-9543-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2013

Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review

Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation

The incidence of inherited porphyrias in Europe

The male reproductive system in classic galactosemia: cryptorchidism and low semen volume

Clinical and biochemical features associated with BCS1L mutation